Cargando…

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1

This research focused on the modification of the functional groups of oseltamivir as neuraminidase inhibitor against influenza A virus subtype H1N1. Interactions of three of the best ligands were evaluated in the hydrated state using molecular dynamics simulation at two different temperatures. The d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tambunan, Usman Sumo Friend, Rachmania, Rizky Archintya, Parikesit, Arli Aditya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Department of Journal of Biomedical Research 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389116/ https://www.ncbi.nlm.nih.gov/pubmed/25859271 http://dx.doi.org/10.7555/JBR.29.20130024

Ejemplares similares

Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens
por: Bakri, Ridla, et al.
Publicado: (2014)

Immunoinformatics Approach in Designing Epitope-based Vaccine Against Meningitis-inducing Bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae Type b)
por: Zahroh, Hilyatuz, et al.
Publicado: (2016)

Screening of commercial cyclic peptide as inhibitor NS5 methyltransferase of Dengue virus through Molecular Docking and Molecular Dynamics Simulation
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2014)

Vaccine Design for H5N1 Based on B- and T-cell Epitope Predictions
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2016)

Molecular dynamics simulation of complex Histones Deacetylase (HDAC) Class II Homo Sapiens with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2013)

In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC)
por: Tambunan, Usman SF, et al.
Publicado: (2011)

Modification of S-Adenosyl-l-Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2017)

Exposing the Molecular Screening Method of Indonesian Natural Products Derivate as Drug Candidates for Cervical Cancer
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2017)

Identification of sequence mutations affecting hemagglutinin specificity to sialic acid receptor in influenza A virus subtypes
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010)

Designing cyclic peptide inhibitor of dengue virus NS3-NS2B protease by using molecular docking approach
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010)

Identification of a better Homo sapiens Class II HDAC inhibitor through binding energy calculations and descriptor analysis
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010)

Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2
por: Tambunan, Usman SF, et al.
Publicado: (2015)

Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase
por: Idrus, Syarifuddin, et al.
Publicado: (2012)

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment
por: Stephanie, Filia, et al.
Publicado: (2021)

Synthesis and Biological Evaluation of NH(2)-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors
por: Hu, Yaping, et al.
Publicado: (2019)

Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting Mycobacterium tuberculosis Transcription
por: Stephanie, Filia, et al.
Publicado: (2022)

M. tuberculosis Transcription Machinery: A Review on the Mycobacterial RNA Polymerase and Drug Discovery Efforts
por: Stephanie, Filia, et al.
Publicado: (2022)

Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate Induces Canine Mammary Cancer Cell Aggressiveness
por: de Oliveira, Joana T., et al.
Publicado: (2015)

Identification of DNA Methyltransferase-1 Inhibitor for Breast Cancer Therapy through Computational Fragment-Based Drug Design
por: Alkaff, Ahmad Husein, et al.
Publicado: (2021)

Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs
por: Tao, Jiaye, et al.
Publicado: (2022)

Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors
por: Wang, Pengfei, et al.
Publicado: (2021)

Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses
por: Duan, Susu, et al.
Publicado: (2014)

Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
por: Xu, Zhichao, et al.
Publicado: (2022)

Enzymatic Properties of the Neuraminidase of Seasonal H1N1 Influenza Viruses Provide Insights for the Emergence of Natural Resistance to Oseltamivir
por: Rameix-Welti, Marie-Anne, et al.
Publicado: (2008)

Design, Synthesis, Biological Evaluation and In Silico Studies of Pyrazole-Based NH(2)-Acyl Oseltamivir Analogues as Potent Neuraminidase Inhibitors
por: Ye, Jiqing, et al.
Publicado: (2021)

A Computational-Experimental Approach Identifies Mutations That Enhance Surface Expression of an Oseltamivir-Resistant Influenza Neuraminidase
por: Bloom, Jesse D., et al.
Publicado: (2011)

Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola
por: Nasution, Mochammad Arfin Fardiansyah, et al.
Publicado: (2018)

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
por: Zhang, Jiwei, et al.
Publicado: (2023)

Structural dynamics insights into the M306L, M306V, and D1024N mutations in Mycobacterium tuberculosis inducing resistance to ethambutol
por: Maladan, Yustinus, et al.
Publicado: (2023)

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses
por: Butler, Jeff, et al.
Publicado: (2014)

Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses
por: Singh, Ashona, et al.
Publicado: (2015)

Reduced Sensitivity of Influenza A (H5N1) to Oseltamivir
por: McKimm-Breschkin, Jennifer L., et al.
Publicado: (2007)

Locking the 150-Cavity Open: In Silico Design and Verification of Influenza Neuraminidase Inhibitors
por: Han, Nanyu, et al.
Publicado: (2013)

Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020
por: Adlhoch, Cornelia, et al.
Publicado: (2023)

A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses
por: Escuret, Vanessa, et al.
Publicado: (2014)

Editorial: Computational drug discovery for emerging viral infections
por: Skariyachan, Sinosh, et al.
Publicado: (2023)

Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
por: Tran-To Su, Chinh, et al.
Publicado: (2013)

Dry extract BNO 1011 inhibits human influenza a replication and neuraminidase activity in oseltamivir-resistant and -sensitive viral strains
por: Seifert, Stephanie, et al.
Publicado: (2013)

Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response
por: Changsom, Don, et al.
Publicado: (2016)

Multi-Influenza HA Subtype Protection of Ferrets Vaccinated with an N1 COBRA-Based Neuraminidase
por: Skarlupka, Amanda L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o2gvgn96lr825if8si52bdfvq7